A $300 billion health problem we can solve together
The G2 Track Medication Adherence Platform
The G2 Track Medication Adherence platform helps treatment and primary care program administrators accurately measure medication and treatment adherence by remotely verifying patients have ingested their medication and remain compliant with their treatment.
Adherence data is shared with EHR systems and available to program administrators in real-time; non-compliance is identified immediately and interventions and supports are deployed quickly and effectively, greatly increasing odds of a successful treatment and recovery.
This helps patients, providers, physicians, practitioners, and health systems provide better treatment programs, more efficient treatment plans and diagnostics solutions, more timely interventions and urgent patient care, and more improved patient outcomes.
Any drug can be used and adherence tracking is completely non-invasive; the biosensor detects the unique nanoparticle ‘fingerprint’ of the drug in real-time, confirming when a specific patient is being compliant with their treatment.
Contact us to discuss how our G2 adherence platform can help improve your patients’ outcomes
About one half of adults or 117 million have one chronic condition and almost one-third have two or more. Among chronic disease patients, approximately 50% do not take their medications as prescribed (one quarter are never even filled). Nearly one-third of heart attack patients are not persistent with their prescribed medications by 6 months.
Medication adherence is a problem that affects all of us. Approximately one half of US adults have at least one chronic condition, and one-third have two or more. Among these patients, approximately 50% do not follow their treatment programs or take their medications as prescribed.
Medication non-adherence reasons include poor insight, negative attitude or subjective response toward medication, previous nonadherence, substance abuse, shorter illness duration, inadequate discharge planning or aftercare environment, and poorer therapeutic alliance (1, 2) .
Even with emerging technology, limited information is available on medication non-adherence factors.
Average treatment compliance rates are just 32% for most illnesses. Downstream adverse health effects, outcomes, and medical costs associated with medication non-adherence are significant and widespread.
Social and provider-patient, condition-specific support and information, and therapy and patient related support to patients through their treatment journey all have shown to significantly increase medication adherence and drive better health outcomes ().
Canary’s Track treatment and medication adherence monitoring platform empowers patients and health system providers with the tools and supports necessary to drive significant adherence improvements for patient populations.
Based on CDC estimates of medication adherence impacts in the US
Up to 30% of new prescriptions are never filled at the pharmacy. Cost can also be a factor causing medication non-adherence -- patients can’t afford to fill their prescriptions or decide to take less than the prescribed dose to make the prescription last longer.
Medication is not taken as prescribed 50% of the time. For patients prescribed medications for chronic diseases, after six months, the majority take less medication than prescribed or stop the medication altogether.
Nonadherence causes up to 50% of chronic disease treatment failures. The Centers for Disease Control and Prevention (CDC) estimates that non-adherence causes 30 to 50 percent of chronic disease treatment failures and 125,000 deaths per year in this country. Twenty five to 50 percent of patients being treated with statins (cholesterol lowering medications) who stop their therapy within one year have up to a 25 percent increased risk for dying.
Conquering Medication Adherence with Each Breath
G2 Track Platform can radically transform healthcare by providing primary care providers with visibility to treatment and medication adherence and compliance, enabling interventional support when needed and driving better patient outcomes.